local
Vaccine to treat ‘neglected disease’ shows promising results
Summary by The Midland Editorial Desk · Based on reporting by Katelyn Carlock , KOSA CBS7 / First Alert 7 (Permian Basin CBS)
· July 1, 2026
· 2 min read
ODESSA, Texas (KOSA) - TTUHSC researchers say a vaccine they’ve been working on for years is showing encouraging early results against schistosomiasis — a parasitic illness that sickens millions of people worldwide.The vaccine is called SchistoShield®, and Texas Tech University Health Sciences Ce...
Story provenance No corrections
Summary created by The Midland Editorial Desk — automated, rule-governed Original reporting Katelyn Carlock, KOSA CBS7 / First Alert 7 (Permian Basin CBS) Original story Read at the source Source published Jul 1, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key takeaway It’s found in nearly 80 countries and is especially common in sub-Saharan Africa.
Why this matters in The Midland
The promising results of the SchistoShield vaccine have significant implications for the Permian Basin area, where Texas Tech University Health Sciences Center is a major player in medical research. As a hub for healthcare innovation, the region stands to benefit from the potential breakthrough in treating schistosomiasis, a disease that affects millions worldwide. The fact that TTUHSC researchers have been working on this vaccine for years, driven by a humanitarian effort, speaks to the institution's commitment to addressing global health issues. With the next step being large-scale trials, the community can expect to see continued collaboration between local researchers, federal agencies, and nonprofit partners. The success of SchistoShield could also have a positive impact on the local economy, as it may attract more funding and talent to the area, further solidifying the Permian Basin's reputation as a center for medical innovation.
About this story
Original reporting by KOSA CBS7 / First Alert 7 (Permian Basin CBS) . The Midland surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KOSA CBS7 / First Alert 7 (Permian Basin CBS) . Have a tip or correction? Contact our newsroom .
Category: local ·
Published: July 1, 2026 ·
Source: KOSA CBS7 / First Alert 7 (Permian Basin CBS) ·
Reading time: 2 min
Get more The Midland stories like this
Free weekly briefing covering local and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? ODESSA, Texas (KOSA) - TTUHSC researchers say a vaccine they’ve been working on for years is showing encouraging early results against schistosomiasis — a parasitic illness that sickens millions of people worldwide.The vaccine is called SchistoShield®, and Texas Tech University Health Sciences Ce...
When was this published? This article was first published on July 1, 2026 by KOSA CBS7 / First Alert 7 (Permian Basin CBS) and curated for The Midland readers.
Who reported this story? This story was reported by Katelyn Carlock at KOSA CBS7 / First Alert 7 (Permian Basin CBS). To learn more about how The Midland selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The Midland, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter